Stem cell therapies developed in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program help patients' own bodies heal tissue damaged by heart disease.
The program develops "off-the-shelf" cell-free therapies to improve accessibility and consistency and to provide patients with lower-cost, high-quality care options.
Researchers in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program combine biology, material science and 3D printing to engineer cardiac tissue.
Research activities in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program focus on the following areas:
- Cellular therapies. Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program researchers are developing next-generation stem cell therapies with optimized regenerative capacity. Learn more about research on cellular therapies.
- Acellular therapies. Researchers have established extracellular vesicles as an alternative to stem cell-based approaches to improve the accessibility and consistency of therapeutic benefit and to lower costs. Learn more about research on acellular therapies.
- Tissue engineering. By combining stem cell and exosome biology, material science, and 3D printing technology, investigators are finding new ways to engineer cardiac tissue. Learn more about tissue engineering research.